Margin dodolan operasi Impact BioMedical, Inc. (IBO)

Lambang korporat lan logo Impact BioMedical (IBO)

The venture status of Impact BioMedical Inc (IBO) and the absence of stable sales create cash flow uncertainty. EBIT profitability visualizes these risks, where the -12623.70 level captures the current state. Revenues are based on the licensing of medical and digital innovations. A monetization strategy for its broad patent portfolio allows the company to avoid direct price competition within the pharmaceutical sector.

IBO - Tingkat bathi operasi Impact BioMedical, Inc. ing rentang 17.09.2024 - 19.11.2026

IBO (impactbiomedinc.com): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:IBO, impactbiomedinc.com
Produk dadi Impact BioMedical Inc

Operating margin reflects the efficiency of converting revenue into profit before taxes and interest, revealing the business's ability to generate income from core operations. By analyzing operating profitability, an investor will see Impact BioMedical Inc (IBO)'s critical dependence on external capital, as the lack of stable sales and the speculative nature of early-stage developments make this indicator extremely volatile and risky.

Analisis perusahaan pesaing

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|PCRX - Rentabilitas dodolan operasi|Margin operasi SPRY (ars-pharma.com)|Tingkat bathi operasi TBPH|Aquestive Therapeutics, Inc. - Margin operasi|scpharmaceuticals.com - Rasio bathi operasi|Tectonic (TECX) - Rentabilitas operasi|Margin dodolan operasi Tonix Pharmaceuticals Inc.|Rentabilitas operasi sxtchina.com|Margin dodolan operasi Eupraxia Pharmaceuticals (EPRX)|Margin operasi BHST|EXOZ - Rentabilitas dodolan operasi|Oramed - Margin dodolan operasi|Entera Bio Ltd. (ENTX) - Rentabilitas dodolan operasi|HYFT - Rentabilitas operasi|ABVC: Rentabilitas operasi|CPIX: Margin operasi|Quantum BioPharma Ltd. - Tingkat bathi operasi|FGEN (FibroGen Corp) - Margin operasi|Telomir Pharma (TELO) - Rentabilitas kegiatan operasi|Rentabilitas operasi Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Tingkat bathi operasi|Rentabilitas operasi Rallybio Corporation RLYB|LEXX: Rentabilitas dodolan miturut bathi operasi|PULM - Rentabilitas operasi|Tingkat bathi operasi PTHL (Pheton Holdings)|Aptorum (APM) - Rentabilitas operasi|LYRA (Lyra Therapeutics) - Rentabilitas operasi|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.